Skip to main content
. 2013 Oct;81(10):3566–3576. doi: 10.1128/IAI.00506-13

Table 2.

Primers used in this study

Primer Sequence (5′ to 3′)a Use and description Reference
SD_hns(F) GCTAGGAGCTCCAGCTTGAAGAAGCACTAGA hns insertional mutation, forward primer, SacI site This study
SD_hns(R) GCTAGTCTAGACCAGAAAGTGCAGAAATTAA hns insertional mutation, reverse primer, XbaI site This study
hns_comp(F) GCTAGCTGCAGTCGGCGATAAAACCTTTCAC hns complementation, forward primer, PstI site This study
hns_comp(R) GCTAGCTGCAGGTTTACCTGAACGTGACGAC hns complementation, reverse primer, PstI site This study
Pm416 TTAAATCTCGAATTCTTCTAGAGATTTACC hns open reading frame, forward primer This study
Pm417 ATGTCTGAATTAACAAAAACTCTACTTAAT hns open reading frame, reverse primer This study
pr40 CGGCTACTCGAGAGATTTACCTGCATCAAGTTG hns 5′ region, forward primer, XhoI site This study
pr41 CGGCTATCTAGAGCACTTTCTGGTGAAACTAAG hns 5′ region, reverse primer, XbaI site This study
pr42 CGGCTATCTAGAATTAATGCGCTTACATCAATA hns 3′ region, forward primer, XbaI site This study
pr37 CGGCTAGAGCTCAGAAGCACTAGATAAATTAAC hns 3′ region, reverse primer, SacI site This study
pr38 CGGCTATCTAGAGAAAAGCTTGAACACGTAGAA Kanamycin resistance gene, forward primer, XbaI site This study
Pm173 ACTGATCTAGATCAGAAGAACTCGTCAAGAAG Kanamycin resistance gene, reverse primer, XbaI site This study
RT vah1-R1 GACCGCCGAATCGATGATGAATC vah1 qRT-PCR, forward primer 4
pvah1JR GGTAGGACTGATGCCCACCTACAA vah1 qRT-PCR, reverse primer This study
plpF RT CAGACGACCACCAGTAACCACTAA plp qRT-PCR, forward primer 4
plpR RT GCAATCATGATGACCCAGCAACAG plp qRT-PCR, reverse primer 4
Pm111 GGAAATTATTCCGCCGACGATGGA rtxA qRT-PCR, forward primer 5
Pm112 GCCGATACCGTATCGTTACCTGAA rtxA qRT-PCR, reverse primer 5
Pm285 GTGATGGTAGAAAACCTGCGG rtxH qRT-PCR, forward primer This study
Pm286 ATGTCTGAGAAATTTGTCCAAACA rtxH qRT-PCR, reverse primer This study
iPCR rtxB R CCGCTAACCGCATTGATATTAAGCTTGGC rtxB qRT-PCR, forward primer This study
Pm104 TCACAATCGCCCCAACTTGCCTTG rtxB qRT-PCR, reverse primer This study
Pm297 ACTGAGAGCTCGGTGTTGTTAAAGGCTATGGC hlyU qRT-PCR, forward primer 6
Pm298 ATCGATCTAGAGTATCCACTAACCCATCTCTT hlyU qRT-PCR, reverse primer 6
Pm412 CCGTATTTTCTGCAATCGCCATGG vah1 promoter region (probe 1), forward primer, 5′ labeled with FAM 6
Pm324 CACATATTGACTGATTATAATTTTATTGATATT vah1 promoter region (probe 1), reverse primer 6
pr323a AGGGTTTTTATAAATCCTAATTTAGATA plp promoter region (probe 2), forward primer, 5′ labeled with FAM This study
Pm320 GAATACCCATTTTTTATTTTTTCAGACC plp promoter region (probe 2), reverse primer 6
Pm327 GTATTTTCTGCAATCGCCATG vah1-plp (probe 3) intergenic region, forward primer 6
Pm413 CACCTTTGTGGCGAATTATTAATAGATCTT vah1-plp (probe 3) intergenic region, reverse primer, 5′ labeled with FAM 6
Pm414 CAGTGGCTCATAAAAGCAGTTGC rtxB-rtxH intergenic region (probe 4), forward primer, 5′ labeled with FAM 6
Pm318 CAGCGGTAAGTAGACTGATA rtxB-rtxH intergenic region (probe 4), reverse primer 6
Pm315 CTCAGACATAAATAAATCACC rtxB-rtxH intergenic region (probe 5), forward primer 6
Pm415 CAGCGGTAAGTAGACTGATAAGCAATG rtxB-rtxH intergenic region (probe 5), reverse primer, 5′ labeled with FAM 6
a

Underlined sequences are engineered restriction sites.